Company intelligence / Profile preview

Modular Medical

San Diego, California, United Statesmodularmedical.com ↗

Ownership: Public · MODD
Development stage: Commercial

Overview

Modular Medical is developing the MODD1, a next-generation, user-friendly and affordable insulin patch pump designed to simplify diabetes management. The company has received FDA clearance for its first patch pump and is pursuing further development including closed-loop automated insulin delivery systems through partnerships. Early-stage research also explores peptide therapy for diabetes and obesity using their platform. No commercial clinical results have been published as of June 2025.

Therapeutic areas: EndocrinologyMetabolic Disorders
Modalities: DevicePeptides
Industry: Therapeutic Medical Devices

Partnerships

Nudge BG (closed loop AID system development)

Financials

Market cap: $5.9M
Total revenue: $0
Enterprise value: $2.3M

Beyond the preview

Go deeper on Modular Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Modular Medical.

Explore the full profile